Dextera Surgical’s Automated Cardiac Anastomotic Devices to Be Featured at 2017 International Coronary Congress
August 17 2017 - 12:10PM
Business Wire
Dextera Surgical Inc. (Nasdaq:DXTR), a company manufacturing and
marketing the only automated anastomotic devices for CABG surgery
on the market, today announced that its C-Port® Distal and
PAS-Port® Proximal Anastomosis Systems will be highlighted in
multiple lectures, abstracts and presentations for their ability to
enable less invasive cardiac procedures at the 2017 International
Coronary Congress (ICC), a medical meeting focused on
state-of-the-art surgical coronary revascularization. The meeting
will be held August 18-20, 2017, in New York, NY.
Several presentations at the meeting highlight the use of
Dextera’s C-Port and PAS-Port Systems to help enable less invasive
coronary artery bypass graft (CABG) procedures. These include:
Abstract A07: Ps Matched Analysis of On-pump, Off-pump
PAS-Port and Anaortic CABG – A Single Center Study in 5422
PatientsSession 8B, 4:26 p.m. to 4:32 p.m., Friday, August 18,
2017Presenter: Prof. Dr. Med. Jan Gummert of Herz-und
Diabeteszentrum Nordrhein-Westfalen in Bad Oeynhausen Germany
Abstract A26: How to Select Proximal Anastomotic Devices and
Procedures to Avoid Perioperative Stroke in CABGSession 9, 7:36
a.m. to 7:42 a.m., Saturday, August 19, 2017Presenter: Dr. Tomohiro
Mizuno of Tokyo Medical and Dental University in Japan
Abstract: Angiographic Outcomes with ‘Minimally Invasive’
CABG from Around the WorldSession 16A, 4:03 p.m. to 4:11 p.m.,
Saturday, August 19, 2017Presenter: Husam H. Balkhy, University of
Chicago Medicine, Chicago, IL
Abstract: Robotic CABG: Role of Anastomotic
ConnectorsSession 18A, 8:40 a.m. to 8:48 a.m., Sunday, August
20, 2017Presenter: Husam H. Balkhy, University of Chicago Medicine,
Chicago, IL
“It’s an exciting time in the field of cardiac surgery today,”
commented Dr. Balkhy, professor of surgery and director of robotic
and minimally invasive cardiac surgery at the University of Chicago
Medicine. “In presenting data from around the world at this
meeting, it is clear that minimally invasive coronary surgery is on
the rise. I’m pleased to report that the automated C-Port® Flex-A®
System which I have been using in my practice for 10 years now,
precisely and reliably connects the graft to the coronary arteries
during coronary bypass procedures. It continues to enable minimally
invasive and endoscopic approaches with remarkable outcomes in my
patients. They consistently are discharged sooner and recover more
quickly than patients undergoing a traditional open-heart coronary
bypass, given the minimally invasive nature of the procedures.”
“The body of evidence supporting the use of automated
anastomosis products during cardiac bypass procedure continues to
grow, with diverse patient populations benefiting from these
devices,” said Prof. Dr. Med. Gummert of Herz-und Diabeteszentrum
Nordrhein-Westfalen in Bad Oeynhausen Germany. “I have used the
PAS-Port System routinely in bypass procedures, because there is no
need to clamp or manipulate the aorta during the procedure, an
activity known to increase the risk of stroke.”
“We are pleased to see global leaders in cardiac surgery
demonstrating the long-term clinical results using the C-Port and
PAS-Port Systems in minimally invasive cardiac surgery in efforts
to improve patient outcomes,” said Julian Nikolchev, president and
CEO of Dextera Surgical. “These important tools continue to enable
leading surgeons to perform bypass procedures less invasively as
the only automated anastomosis products on the market today.”
About the C-Port® Distal Anastomosis
Systems (C-Port systems)
The C-Port Anastomosis Systems are intended for use in the
creation of anastomoses in blood vessels and grafts, including use
in coronary artery bypass grafting procedures. The C-Port Systems –
the C-Port xA System and the Flex-A® System – can be used on-
or off-pump and create compliant anastomoses that expand and
contract with blood flow. The C-Port Systems work on coronary
arteries as small as 1.3 millimeters in internal diameter and work
with grafts of various diameters and vessels with single wall
thicknesses less than 0.75 millimeters. The Flex-A System allows
surgeons to position the device to create a secure connection even
in difficult to reach areas of the heart. The C-Port System
received 510(k) clearance in 2006 and the Flex-A System in
2007.
About the PAS-Port® Proximal Anastomosis
System
The PAS-Port® System is intended to create the aortic
anastomosis of aortic autologous vein grafts. The PAS-Port system
is a fully-automated device used to perform an anastomosis between
a saphenous vein and the aorta during either on- or off-pump CABG
surgery. The PAS-Port system has been used in Japan and Europe
since 2004, and received 510(k) clearance in the United States in
2008. The PAS-Port system allows a surgeon to complete an
automated connection of the bypass graft vessel to the aorta (known
as a proximal anastomosis) without the need to clamp and manipulate
the aorta. The common method of completing a proximal anastomosis
in CABG surgery often requires that the aorta be clamped and
utilizes time-consuming hand-sewn sutures. When the clamp is
released, tiny blood clots or particles from the aortic wall can be
released, which can then travel to the brain and cause stroke and
other neurologic complications. In addition, the PAS-Port's unique
design allows for a comparable take-off angle when compared to
hand-sewn sutures, and the PAS-Port's implant design does not
introduce metal into the graft lumen.
About Dextera Surgical
Dextera Surgical designs and manufactures proprietary
stapling devices for minimally invasive surgical procedures. In the
U.S., surgical staplers are routinely used in more than one million
minimally invasive laparoscopic, video-assisted or robotic-assisted
surgical procedures annually.
Dextera Surgical also markets the only automated
anastomosis devices for coronary artery bypass graft (CABG) surgery
on the market today: the C-Port® Distal Anastomosis Systems and
PAS-Port® Proximal Anastomosis System. These products, sold
by Dextera Surgical under the Cardica brand name, have
demonstrated long-term reliable clinical performance for more than
a decade.
Forward-Looking Statements
The statements in this press release regarding the benefits
patients may obtain from the use of Dextera Surgical’s C-Port and
PAS-Port Systems are "forward-looking statements." There are
several important factors that could cause Dextera Surgical’s
results to differ materially from those indicated by these
forward-looking statements, including the risks detailed from time
to time in Dextera Surgical’s reports filed with the U.S.
Securities and Exchange Commission, including its Quarterly Report
on Form 10-Q for the quarter ended March 31, 2017, under the
caption “Risk Factors.” Dextera Surgical expressly disclaims any
obligation or undertaking to release publicly any updates or
revisions to any forward-looking statements contained herein. You
are encouraged to read Dextera Surgical’s reports filed with the
U.S. Securities and Exchange Commission, available at
www.sec.gov.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170817005780/en/
Dextera Surgical Inc.Bob Newell, 650-331-7133Vice President,
Finance and Chief Financial
Officerinvestors@dexterasurgical.com